Cromwell Holdings’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
AT
DJSG
CIM
AC
MPWT
NAM
CNB
Cromwell Holdings's RMD Position: Q2 2026 in Review
Cromwell Holdings increased its ResMed (RMD) stake by 3.2% in Q2 2026, buying an estimated $3.11K and bringing the position to 485 shares worth $94.5K. The position accounts for 0.04% of the portfolio, ranked #366.
Cromwell Holdings first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $129K in Q3 2025. 142 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Cromwell Holdings held 485 shares of ResMed worth $94.5K as of Q2 2026.
- Cromwell Holdings bought 15 ResMed shares in Q2 2026, an estimated $3.11K.
- ResMed made up 0.04% of Cromwell Holdings's portfolio in Q2 2026, its #366 holding.
- Cromwell Holdings first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
- Cromwell Holdings's ResMed position peaked at $129K in Q3 2025.
- 142 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.